Paper highlight: New driver of T cell leukemia growth

NKX3.1, a protein that suppresses the development of prostate tumors, promotes the growth of a different type of tumor in the blood, according to an article published online on September 20 in the Journal of Experimental Medicine.

Paul-Henri Romeo and colleagues find that TAL1, a abundantly expressed in approximately 40% of patients with T cell acute lymphoblastic leukemia (T-ALL), drives expression of NKX3.1. Eliminating NKX3.1 halted the growth of TAL1-expressing T-ALL cells in culture and after injection into mice.

It's not yet clear how NKX3.1 sustains the growth of T-ALL cells, but these findings show that this protein can either halt or hasten tumor development depending on the tissue environment.

More information: Kusy, S., et al. 2010. J. Exp. Med. doi:10.1084/jem.20100745. www.jem.org/

Citation: Paper highlight: New driver of T cell leukemia growth (2010, September 20) retrieved 28 March 2024 from https://medicalxpress.com/news/2010-09-paper-highlight-driver-cell-leukemia.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

New type of adult stem cells found in the prostate may be involved in prostate cancer development

 shares

Feedback to editors